SIMION, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 490
EU - Europa 89
AS - Asia 53
OC - Oceania 7
SA - Sud America 1
Totale 640
Nazione #
US - Stati Uniti d'America 486
CN - Cina 52
IT - Italia 34
FI - Finlandia 19
GB - Regno Unito 9
UA - Ucraina 9
AU - Australia 7
DE - Germania 5
SE - Svezia 4
HN - Honduras 3
IE - Irlanda 3
FR - Francia 2
NL - Olanda 2
CL - Cile 1
GR - Grecia 1
IN - India 1
PA - Panama 1
PL - Polonia 1
Totale 640
Città #
Chandler 102
Fairfield 52
Ashburn 49
Beijing 24
Cambridge 23
Woodbridge 23
Seattle 21
Wilmington 21
Houston 18
Helsinki 16
Medford 14
Princeton 14
Ann Arbor 11
San Diego 9
Mykolayiv 8
Roxbury 8
Sydney 7
London 6
New York 6
Legnaro 5
Des Moines 4
Milan 4
Los Angeles 3
Padova 3
Atlanta 2
Avellino 2
Lappeenranta 2
Novara 2
Shenyang 2
Tegucigalpa 2
Boardman 1
Chicago 1
Edinburgh 1
Gassino Torinese 1
Hebei 1
Hefei 1
Hounslow 1
Istrana 1
Kharkiv 1
Ningbo 1
Norwalk 1
Nürnberg 1
Panama City 1
Prescot 1
Pune 1
Salzano 1
San Pedro Sula 1
Tolbert 1
Zogno 1
Totale 482
Nome #
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 89
More severe hypercoagulable state in acute COVID-19 pneumonia as compared to other pneumonia 83
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 60
Incidence of VTE in asymptomatic children with deficiencies of antithrombin, protein C, and protein S: a prospective cohort study 54
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 53
Risk Factors for Post-Thrombotic Syndrome in Patients With a First Proximal Deep Venous Thrombosis Treated With Direct Oral Anticoagulants 39
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review 34
Prothrombotic risk factors in pregnancy 33
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 30
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 28
Evaluation of Covid-19-Associated Hypercoagulability with Functional Coagulation Assays and Extracellular Vesicles 26
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review 23
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 23
Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation 20
Mechanisms of thrombosis in pancreatic ductal adenocarcinoma 17
Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project 14
Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection 13
POST-discharge thromboprophylaxis in patients with COVID-19: a single-center experience 7
Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis 5
Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project 3
Totale 654
Categoria #
all - tutte 4.391
article - articoli 4.391
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 4 4
2019/202036 3 4 0 2 4 2 4 5 7 3 0 2
2020/2021118 0 2 0 0 49 7 5 11 15 12 14 3
2021/2022125 0 0 6 1 11 9 2 20 14 3 12 47
2022/2023207 33 24 5 17 30 19 2 16 40 3 11 7
2023/2024160 2 25 13 24 14 49 23 1 4 4 1 0
Totale 654